International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy

Table 2 Characteristics of hepatic encephalopathy in whole population and comparison between patients readmitted early or not, n (%)

Variable	Whole population	Readmitted	Non-readmitted	P-value
	(n = 213)	(n = 65)	(n = 148)
Incentives of HE				0.645
No obvious incentive	114 (54)	35 (54)	79 (53)
High protein diet	47 (22)	12 (18)	35 (24)
Infection	16 (8)	6 (9)	10 (7)
GI bleeding	15 (7)	7 (11)	8 (5)
Electrolyte disturbances	3 (1)	1 (2)	2 (1)
Other	18 (8)	4 (6)	14 (9)
Degree of HE				0.341
I	139 (65)	39 (60)	100 (68)
II	49 (23)	15 (23)	34 (23)
III	21 (10)	10 (15)	11 (7)
IV	4 (2.0)	1 (2.0)	3 (2.0)
Treatment for HE				0.523
L + AO	139 (65)	48 (74)	91 (62)
L + R + AO	1 (0.5)	0 (0)	1 (0.7)
L	2 (0.9)	1 (1.5)	1 (0.7)
WVE + AO	1 (0.5)	0 (0)	1 (0.7)
AO	61 (29)	15 (23)	46 (31)
Nothing	3 (1.4)	0 (0)	3 (2.0)
L + AO + WVE	6 (2.8)	1 (1.5)	5 (3.4)

AO: Aspartate ornithine; GI: Gastrointestinal; HE: Hepatic encephalopathy; L: Lactulose; R: Rifaximin; WVE: White vinegar enema.